Viewpoint: Leprosy after the year 2000

Tropical Medicine and International Health

Volumn 5, Issue 6, 2000, Pages 400-403

  Naafs, Ben ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Leprosy; Public Health; Treatment

Indexed keywords

CLOFAZIMINE; DAPSONE; DAPSONE DERIVATIVE; GLUCOSULFONE; RIFAMPICIN;

DRUG EFFICACY; DRUG INDUCED DISEASE; HEALTH CARE DELIVERY; HUMAN; LEPROSY; LEPROSY CONTROL; LEPROSY EPIDEMIOLOGY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NOTE; PATIENT COMPLIANCE; RELAPSE; TREATMENT OUTCOME; TREATMENT PLANNING;

CLOFAZIMINE; DRUG THERAPY, COMBINATION; HUMANS; HYPERSENSITIVITY, DELAYED; LEPROSTATIC AGENTS; LEPROSY; PREVALENCE; PUBLIC HEALTH; RIFAMPIN; SKIN; WORLD HEALTH;

MYCOBACTERIUM AVIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 0033941354     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2000.00579.x     Document Type: Note

References (25)

1. Browne SG (1984) Leprosy. In: Acta Clinica, 3rd edn. Ciba-Geigy, Basle.
2. Bushby SRM (1964) Chemotherapy. In: Leprosy in Theory and Practice, 2nd edn (eds RG Cochrane & TF Davey), John Wright and Sons, Bristol, pp. 344-370.
3. Ekambaram V & Sithambaram M (1977) Self-healing in non-lepromatous leprosy in the area of the ELEP Leprosy Control Project Dharmapuri (Tamil Nadu). Leprosy in India 49, 387-392.
4. First International Leprosy Congress (1897) Final Statement. Berlin.
5. Jacobson RR & Krahenbuhl JL (1999) Leprosy. Lancet 353, 655-660.
6. Katoch VM (1998) Is there a microbiological rationale for single dose treatment of leprosy? Leprosy Review 69, 2-5.
7. Lockwood DN (1997) Rifampicin/Minocycline and Ofloxacin (ROM) for single lesions - What is the evidence? Leprosy Review 68, 299-300.
8. Lynch P (1999) Multidrug therapy. (Letter). Leprosy Review 70, 70-71.
9. Naafs B (1988) The treatment of leprosy. In: Mycobacterial Disease: Developments in Serodiagnosis and Therapy (ed. DW Mulder) Royal Tropical Institute, Amsterdam, Bull. 313, 58-78.
10. Naafs B (1998) Leprosy, no longer a public health problem after the year 2000. A political statement to be met. Memisa Medisch 64, 103-106.
11. Naafs B, Lyons NF, Madombi L, Matemera BO & Ellis BPB (1986) Short term WHO advised Multi Drug Treatment of Paucibacillary Leprosy Patients. Indian Journal of Leprosy 58, 348-353.
12. Noordeen SK (1993) Epidemiology and control of leprosy - a review of progress over the last 30 years. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 515-517.
13. Pönnighaus JM & Boerrigter G (1995) Are 18 doses of WHO/MDT sufficient for multibacillary leprosy? Result of a trial in Malawi. International Journal of Leprosy 65, 1-7.
14. Post E, Chin-A -Lien RAM, Bouman C, Naafs B & Faber WR (1994) Lepra in Nederland in de periode 1970-1991. Nederlands Tijdschrift voor Geneeskunde 138, 1960-1963.
15. Prabhavolkar AB & Ansari K (1997) Patterns of indoor admissions of leprosy patients in pre-MDT and post-MDT era and a role for a leprosy referral hospital in a leprosy integration programme. Indian Journal of Leprosy 69, 159-167.
16. Rogers L & Muir E (1940) Prophylaxis. In: Leprosy, 2nd edn (eds 1. Rogers & E Muir), John Wright and Sons Ltd, Bristol, pp. 98-138.
17. Shepard CC, Levy L & Fasal P (1969) The sensitivity for dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. American Journal of Tropical Medicine and Hygiene 18, 258-264.
18. Van Brakel WH (1999) Proposal regarding MB MDT (Letter to the Editor). Leprosy Review 70, 71-73.
19. Visschedijk J, Van den Broek J, Eggens H, Lever P, Van Beers S & Klatser P (2000) Mycobacterium leprae - Millennium resistant! A review of leprosy control on the threshold of a new era. Tropical Medicine and International Health 5, 388-399.
20. Waters MF (1993) Chemotherapy of leprosy - current status and future prospects. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 500-503.
21. Waters MF (1998) Is it safe to shorten multidrug therapy of lepromatous (LL and BL) leprosy to 12 months? Leprosy Review 69, 110-111.
22. WHO (1982) Chemotherapy of leprosy for control programmes. Technical Report Series 675, WHO, Geneva.
23. WHO (1994) Chemotherapy of leprosy. Technical Report Series 847, WHO, Geneva.
24. WHO (1985) Expert Committee on Leprosy Sixth report. Technical Report Scries 768, WHO, Geneva.
25. WHO (1998) Expert Committee on Leprosy Technical Report Series 874, WHO, Geneva.